| Biomarker ID | 1272 |
| PMID | 24371517 |
| Year | 2013 |
| Biomarker | Integrin α3 [ITGA3] |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Urine |
| Subjects | Humans |
| Regulation | Upregulated in Metastatic Prostate Cancer |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: Dilated cardiomyopathy, Hematopoietic cell lineage, Cell surface interactions at the vascular wall, Integrin-mediated cell adhesion, Integrin cell surface interactions |
| Experiment | Metastasis Vs Prostate Cancer and BPH |
| Type of Biomarker | Diagnostic |
| Cohort | Patients with Benign Prostatic Hyperplasia BPH (n=5), Prostate Cancer PCa (n=5) and metastatic PCa (n=3) were selected for evaluation of protein expression in the exosomes |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.005 |
| Method Used | Western Blotting |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on Human Patient Cohort |
| Technical Name | ITGA3 |